Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0001012975-22-000076
Filing Date
2022-02-14
Accepted
2022-02-14 09:21:52
Documents
2
Period of Report
2021-12-31
Effectiveness Date
2022-02-14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2286
2 INFORMATION TABLE infotable.html INFORMATION TABLE  
2 INFORMATION TABLE infotable.xml INFORMATION TABLE 5876
  Complete submission text file 0001012975-22-000076.txt   9323
Mailing Address 501 2ND ST, SUITE 200 SAN FRANCISCO CA 94107
Business Address 501 2ND ST, SUITE 200 SAN FRANCISCO CA 94107 415-948-7474
Pivotal bioVenture Partners Investment Advisor LLC (Filer) CIK: 0001844645 (see all company filings)

EIN.: 814749159
Type: 13F-HR | Act: 34 | File No.: 028-20630 | Film No.: 22626134